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Abstract
Background: Chlamydiae are obligate intracellular bacteria that multiply in a vacuolar compartment, the inclusion.
Several chlamydial proteins containing a bilobal hydrophobic domain are translocated by a type III secretion (TTS)
mechanism into the inclusion membrane. They form the family of Inc proteins, which is specific to this phylum.
Based on their localization, Inc proteins likely play important roles in the interactions between the microbe and the
host. In this paper we sought to identify and analyze, using bioinformatics tools, all putative Inc proteins in
published chlamydial genomes, including an environmental species.
Results: Inc proteins contain at least one bilobal hydrophobic domain made of two transmembrane helices
separated by a loop of less than 30 amino acids. Using bioinformatics tools we identified 537 putative Inc proteins
across seven chlamydial proteomes. The amino-terminal segment of the putative Inc proteins was recognized as a
functional TTS signal in 90% of the C. trachomatis and C. pneumoniae sequences tested, validating the data
obtained in silico. We identified a macro domain in several putative Inc proteins, and observed that Inc proteins are
enriched in segments predicted to form coiled coils. A surprisingly large proportion of the putative Inc proteins are
not constitutively translocated to the inclusion membrane in culture conditions.
Conclusions: The Inc proteins represent 7 to 10% of each proteome and show a great degree of sequence
diversity between species. The abundance of segments with a high probability for coiled coil conformation in Inc
proteins support the hypothesis that they interact with host proteins. While the large majority of Inc proteins
possess a functional TTS signal, less than half may be constitutively translocated to the inclusion surface in some
species. This suggests the novel finding that translocation of Inc proteins may be regulated by as-yet
undetermined mechanisms.
Background
Members of the phylum Chlamydiae form a phylogen-
etically well-isolated group of bacteria. It includes the
family Chlamydiaceae, which are pathogenic bacteria
infecting a wide range of Vertebrates, as well as sym-
bionts of free-living amoebae and other eukaryotic
hosts, often referred to as environmental chlamydiae [1].
The most prominent member of the phylum is Chlamy-
dia trachomatis, an exclusively human pathogen, which
is the leading cause of preventable blindness and of
sexually transmitted diseases of bacterial origin [2,3].
The other important species for public health is
Chlamydia pneumoniae, a causative agent of pneumo-
niae, which has also been associated with a number of
chronic diseases such as atherosclerosis, adult-onset
asthma and Alzheimer’s disease [4]. Although not clearly
documented, a role for environmental chlamydiae in
human diseases cannot be excluded.
In addition to relatedness at the genomic level, mem-
bers of the phylum share two characteristics: an obligate
intracellular lifestyle and a unique biphasic developmen-
tal cycle [5]. Infection starts with the attachment of the
infectious form of the microorganism, the elementary
body, to a eukaryotic host cell. Upon attachment, intra-
cellular signaling events lead to the internalization of
the bacterium in a membrane-bound compartment
called an inclusion. Importantly, the remainder of the
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ment. Internalized, infectious particles differentiate
immediately to metabolically active bacteria, or reticu-
late bodies, which replicate in the inclusion. At the end
of the developmental cycle, the bacteria differentiate
back into elementary bodies that are released to the
extracellular space to initiate a new infectious cycle.
The inclusion membrane is a key player in the interac-
tions between chlamydiae and the host cell. Its composi-
tion dictates the exchanges between the lumen of the
inclusion, in which the bacteria reside, and the host
cytoplasm. Microscopy studies indicate that chlamydiae
incorporate membranes from several intracellular com-
partments [6-9]. However, very few eukaryotic proteins
h a v eb e e ns h o w nt ob ei nt h ei n c l u s i o nm e m b r a n e .I n
contrast, many different proteins of bacterial origin have
been found in this location. The first one, IncA, was iso-
lated based on its immunogenicity, as antibodies against
this protein were abundant in sera of convalescent guinea
pigs [10]. Subsequently, homologs of IncA have been
found in all Chlamydiaceae species, and the protein was
shown to play a central role in controlling the fusion of
inclusions and the interactions between the inclusion and
intracellular compartments [11-13]. Following the discov-
ery of IncA, other inclusion membrane proteins were
identified and designated as Inc proteins (Inclusion pro-
teins) [14,15]. In addition to their localization to the inclu-
sion membrane, they share a feature that became a
hallmark of the family: a large hydrophobic domain of 40
to 60 residues with hydrophilic residues in its middle, giv-
ing it a bilobal pattern on hydropathy plots. Access to gen-
ome sequences of chlamydiae revealed an abundance of
proteins with such a profile. A manual approach identified
46 C. trachomatis and 70 C. pneumoniae proteins with
one or two bilobal hydrophobic domain [16]. Antibodies
against five out of six predicted members of the Inc family
demonstrated their localization to the inclusion mem-
brane, thus confirming their designation as Inc family
members. Three years later, based on the 13 Inc proteins
identified at the time, a second study used an in silico
approach to predict Inc proteins in the same two human
pathogens. Based on somewhat different criteria, this sec-
ond list differs slightly from the first one, but confirms the
specificity of Inc proteins to Chlamydiae genomes and the
extension of the family in C. pneumoniae compared to
C. trachomatis [17]. To date, C. trachomatis is by far the
species for which the Inc catalog is best characterized,
with about twenty members [18]. Only a handful has been
characterized using specific antibodies in other species,
including very recently the environmental species Proto-
chlamydia amoebophila (see references in Table 1).
The bilobal hydrophobic domain of Inc proteins is
predicted to enable its insertion into the inclusion mem-
brane, although, in the absence of genetic tools to
manipulate chlamydiae, it is difficult to demonstrate.
F u r t h e r m o r e ,i ti sa s s u m e dt h a ta tl e a s to n es e g m e n to f
the protein faces the cytosol of the host. This has been
demonstrated in a few cases, either directly by microin-
jecting antibodies into the cytoplasm, or indirectly by
identifying eukaryotic partners [19-22]. Type III secre-
tion (TTS) signals have been found in the amino term-
inal domain of several Inc proteins, indicating that this
is the secretion mechanism used to transit the bacterial
outer membranes [23,24]. The precise mechanism by
which the proteins, following transit through the secre-
tion needle, are inserted in the inclusion membrane is
unknown.
From their localization at the interface between the
bacteria and the host, Inc proteins are expected to be
involved in varied processes. However, only a few
interactions between Inc proteins and eukaryotic pro-
teins have been described (listed with references in
Table 1), and, for the most part, their exact function
in infection is totally unknown. Genes coding for the
Inc proteins are not all expressed at the same time
during the developmental cycle [25,26], indicating that
the proteins participate in the maturation of the inclu-
sion membrane and might be only transiently present
on the membrane, fulfilling a function limited to cer-
tain stages of development. Early comparisons of the
putative Inc proteins of C. trachomatis and C. pneumo-
niae indicated that only a subset is conserved between
these two species [16]. For those which are conserved,
t h el e v e lo fs i m i l a r i t yi su s u a l l yv e r yl o w ,a n dt h eI n c
proteins are among the least conserved proteins when
comparing the two species. This is somewhat surpris-
ing if Inc proteins are involved in key interactions
between the bacteria and the host, which are expected
to be conserved in all Chlamydiaceae species. One par-
tial answer to that intriguing question may come from
the observation that many of the Inc proteins are
immunogenic during C. trachomatis infection in
humans [18]. To counterbalance their exposure to the
host immune system, genes coding for Inc proteins
might be subjected to a higher rate of modification
than the rest of the genome.
Since the early manual description of putative Inc pro-
teins in the C. trachomatis and C. pneumoniae pro-
teomes, seven different species of Chlamydiaceae have
been sequenced, including one species of an environ-
mental chlamydiae, Protochlamydia amoebophila.
Furthermore, more than thirty putative Inc proteins
have now been validated using specific antibodies,
mostly in C. trachomatis (Table 1). We used this infor-
mation to identify features characteristic of all Inc pro-
teins, which we used in a systematic computer-based
approach to identify all putative Inc proteins in
published chlamydial genomes. Using a heterologous
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majority of these proteins contained a functional TTS
signal. This result validated our criteria for the in silico
identification of Inc proteins. In spite of their ability to
be recognized as TTS substrates, many putative Inc pro-
teins are not detected at the inclusion membrane during
in vitro culture, suggesting that their translocation
might be controlled by an unknown mechanism.
Results
Inc protein hydrophobic domains consist of two
transmembrane alpha helices
The hallmark of Inc proteins is a large hydrophobic
domain of 40 to 60 residues with non-hydrophobic resi-
dues in its middle, resulting in a bilobal pattern on
hydropathy plots [16]. While it is assumed that this
hydrophobic domain serves as an anchor in the inclusion
Table 1 Chlamydial Inc proteins observed on the inclusion membrane using specific antibodies
Name Ortholog Group #
(this study)
Proposed Partner/Function Reference
CAB0766 842 [73]
CCA0491 (IncB) 79 [14]
CF0218 842 [74]
CPn0146 287 [37]
CPn0147 455 [37]
CPn0186 264 [16]
CPn0308 No ortholog [75]
CPn0517 (CP0236) No ortholog Act1 [22] [22]
CPn0585 842 Rab GTPases [20] [76]
CPn1027 No ortholog [77]
CT101 236 [35]
CT115 (IncD) 987 [15]
CT116 (IncE) 982 [15]
CT117 (IncF) 961 [15]
CT118 (IncG) 988 14-3-3 b [21] [15]
CT119 and
CCA0550 (IncA)
264 IncA and SNARE domains [13,78] [10,11]
CT147 553 Similarity to EEA1 [26] [26]
CT222 No ortholog [35]
CT223 842 [16]
CT225 No ortholog [18]
CT226 979 [66]
CT228 964 [18]
CT229 965 Rab4 [79] [16]
CT233 and
CCA0490 (IncC)
26 [14,23]
CT249 966 [80]
CT288 774 [16]
CT358 968 [18]
CT440 411 [18]
CT442 515 [16]
CT618 612 [81]
CT813 978 SNARE domains [13] [65]
CT850 151 [35]
pc0156 344 [82]
pc0399 No ortholog [82]
pc0530 No ortholog [82]
pc1111 No ortholog [82]
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gated. The most common secondary structure for trans-
membrane segments is the alpha helix; other structures
include short buried hydrophobic helices or beta-barrels
[27]. We submitted the sequences of 31 known Inc pro-
teins (listed in Figure 1) to Split analysis, which predicts
the secondary structure of the transmembrane domains
of membrane proteins [28]. In all cases, Split analysis pre-
dicted that Inc protein hydrophobic domains correspond
to two alpha helical transmembrane segments, ranging
from 15 to 32 residues, connected with a short loop of 3
to 22 residues.
The proximity of two helical segments suggested that
they might constitute transmembrane helical hairpins,
which consist of two closely spaced transmembrane
helices separated by a tight turn loop with charged resi-
dues in the flanking regions [29,30]. To test this hypoth-
esis, the sequences of known Inc proteins were
submitted to Topcons, which established a consensus
prediction of membrane protein topology based on dif-
ferent programs and allowed us to define the limits of
the helices and of the loop [31]. Amino acids found in
the loop between the helices were then subjected to the
“turn propensity scale” of helical hairpins [30]. Residues
known as turn-forming residues were enriched in the
loop. Interestingly, helix-breaking Pro and Gly residues
were over-represented as were the polar amino acid Asn
and semi-polar Ser and Thr residues, whereas high
turn-forming charged residues Lys, Arg, Asp, Glu were
absent (Figure 1).
In conclusion, the length and composition of known
Inc proteins are compatible with the topology observed
for transmembrane domains separated by a loop [32].
Loop length was on average of 8 residues, however a
minority of Inc proteins such as IncB and IncC pre-
sented a notably longer loop (15-22 residues). Most Inc
proteins identified so far have only one transmembrane
helical hairpin, with the exception of CT147, CT288 and
CT850, which have two.
In silico identification of all putative inc genes in seven
chlamydial genomes
To systematically identify all inc genes in fully
sequenced Chlamydiae genomes we designed a biocom-
putational approach based on the presence, in all Inc
proteins, of at least two transmembrane domains sepa-
rated by a loop region ([16-18] and this study). Because
the maximum size of the loop region of known Inc pro-
teins is 22 amino acids (Figure 1), we set a threshold of
30 residues between the two transmembrane segments.
           -----------MMMMMMMMMMMMMMMMMMMMM llllllllllllllllllllll MMMMMMMMMMMMMMMMMMMMM-------------------- 
CT115      PSNSLPTAKRLVAVAVATILAVALLVVAGLLF SGVLCSPVSVL            AASLFFGVGAFLLGGALVGGVLTTEAVTRERLHRSQTLMWN 
CT116      LTQGTTAEKVQLVVSCLGVVCSIICLALGIAA AAVGVSCSGF             AIGLGVIAILLGIVLFAISALDVLEDHGLVGCPFKLPCKSS 
CT117      RVVGALAKVAKLVVALAALVLNGALCVLSLVA LCVGATPVGP             LAVLVATTLASFLCAACVLFIAAKDRGWIASTNKC 
CT118      SVTKCLQTAKQAAVLALSLFAVFASGSLSILS AAVLFSGTAAVLP          YLLILTTALLGFVCAVIVLLRNLSAVVQSCKKRSPEEIEGA 
CT119      PQPSLMDKIKKIAAIASLILIGTIGFLALLGH LVGFL                  IAPQITIVLLALFIISLAGNALYLQKTANLHLYQDLQREVG 
CT223      KTGSGLCYKISAVAALVLGLLAAAGGAVVLAL FCTFAPP                FFYAGVALVALGAVILGVGVSNTCSCCLRSRKIEAHKQLIL 
CT225      SFIHRSKTYQLFVVVLTSLLAALGGVFLCLGG VYSS                   LVLGVVGGAAIIGSCIGAFGLVSYLLSVIRNSDQLLQEAKE 
CT226      QTTTSRKEQLLAIGALVLGVLAVLGGALLLLF SGSVVSLFAPI            LSLLAMTLGSACIGGSLVYMYGFSLKPTRLPSESSELAPEA 
CT228      TKGNTCSKILDIALAIVGALVVVAGVLALVLC ASNV                   IFTAIGIAALIIGSACVGAGISRLMCRSSYASLEAKNVLAE 
CT229      QMCSARVGAKTCGIALTIIGLLVATAGVVIAA VGIGTP                 ASLAAGMILVMVGSLLLGLGLARARSRRVEVERHLEVVSMQ 
CT232      QIPTSKKVMIAIMTLFALTAIAAIVLSIVTVC GGFPFLLAALNTVTI        GACVSLPVFTCIATTLLLLCLRNIELLARPQVFTLSTQFSP 
CT233      GSLGLGPQFLAACLVAATILAVAVIVLASLGL GGVLPFVLVCLAGSTNAIWA   IVSASITTLICCVSIACIFLAKCDKGSDPQTLYVS 
CT249      LKSECTAKVARYALGFLFGLGFILSIVTFIAA AATLP                  LGTVTILIMVTQAAFAAALAFKLYDLFKHDVPTCSITSKA 
CT358      QGRPWPVIVSQIALLIMRISSIIVLGLGIAFL ASNPMLGW               SLLIAAITLAISSLLCAIAISVYQTLTIRKLQSEVSSLERQ 
CT440      NQRVTFFRNTAMLTCSLLFTLCSAVLFIIGLF PQTTIPFAGA             FFVIGMFLAFSALCIFLMALIYNVKNWLSHRPIPLPLFSNI 
CT442      KERISNLLSSTAFKVGLVVIGLLLVIATLIFL VSAASFVN               AIYLVAIPAILGCVNICVGILSMEGHCSPERWILCKKVLKT 
CT618      FMARLKRARASMFNLLCSIFDLLAQAFCFISD AVST                   AFMGVHTAFIVGIFCFLSALGNVILSFAF 
CT813      GSRKDPLAKTSWIAGLICVVAGVLGLLAIGIG GCSMASGLGLIG           AIVAAVIVAVGLCCLVSALCLQVEKSQWWQKEFESWIEQKS 
CPN0146    PFKKSLSDAPRVVCSILVLTLGLGALVCGIAI TCWCVPGVI              LMGGICAIVLGAISLALSLFWLWGLFSNCCGSKRVLPGEGL 
CPN0147    EERATSIARSVIAAIIAVVAISLLGLGLVVLA GCCPLGM                AAGAITMLLGVALLAWAILITLRLLNIPKAEIPSPGNNGEP 
CPN0186    KPRSSFIEKVIIVAKYILFAIAATSGALGTIL GLSGALTP               GIGIALLVIFFVSMVLLGLILKDSISGGEERRLREEVSRFT 
CPN0308    THRYCSWVFFKPILVSLGLLLASLTTLGLVIA SGVTLS                 LGIGIVLAIQIVLAGIALVLAFNHIRQFKQARTAELNSMKM 
CPn0585    QQCGWNHTIVKVSLIILLLTILGGGLLVGLL- PAVPM                  FIGTGLIALGAVIFALALILCLYDSQGLPEELPPVPEPQQI 
CPN1027    LIQPHAVLKISILIFALVTILGIVLVVLSSAL GALPS                  LVLTVSGCIAIAVGLIGLGILVTRLILSTIRKVDAMGYDAA 
CCA00550   GRSPLLQRICYLVKIIAAIALFVVGIAALVCL YLGSVIST               PSLILMLAIMLVSFVIVITAIRDGTPSQVVRHMKQQIQQFG 
CCA00490   TPANVCSGPMALAAFLLAISLVAIIIIVLASL GLAGILPQAAAILVNTANSIWA IVSASIVTVICLISVLCITLIRHHKPLPIE 
CCA00491   PPSLCAKLTALALTIIALIAITVLVICIVTVC GGFPLFISLLNMYTV        GACISLPIISCAAVSMMILCSHSINLLRNRPAIYMTNNFQT 
CAB766     ISSNKYQRLATVIALLAGMVLVGTLIGALVCF ALPAS                  LTLVALVSTSLLASVILLSMSVYNLVSQFRRASSYAQIGK 
CF0218     WKVSLNKYQQVAAAIILIAGLVLIGSLVGALV FFALTGPS               VLFAAMLMALVSGVVLIAMAGYQLAVGVRKDAKERQLVHEK 
CT147a     ELKKLRIYEIALKILTIIGAAILFAVPLCMLL GVP                    LWIPIVTCIGVGIAFSIAKGCLQKRCQQIREEYRALHLYHR 
CT147b     GLRGSLRNAMITKAVVAAVLSVAFSCLAIALF SVQ                    LTWLPIMLCVLALVLEAIPSALSIWVEETAQSLIPATKILP 
CT288a     DKHPQIAKAMRITGIALAALSLLAVVACVIAV SAGGAAIP               LAVISGIAVMSGLLSAATIICSAKKALAQRKQKQLEESLPL 
CT288b     ANTLSHASRTLYTVLKVALSLGVLAGVAALII FLPPSLPFI              AVIGVSSLALGMASFLMIRGIKYLLEHSPLNRKQLAKDIQK 
Figure 1 Composition of the bilobal hydrophobic domain of known Inc proteins. Bilobal domains were aligned manualy utilizing the
topological information obtained from Topcons. Identifiers with a and b correspond to the first bilobal (a) and second bilobal (b) domains of
CT147 and CT288. Transmembrane residues are in green, flanking regions charged residues in blue, residues with a high potential to form turns
in red (turn propensity scale: P>N>R>D>Q>H>K>E>G>W>S>Y>T|C M I V A F L[30]). M = transmembrane domain, l = loop domain. Note that
transmembre domain limits were predicted by Topcons and may vary from the limits predicted by Polyphobius and reported in Tables 2, 3 and
in the Additional files 1, 2, 3, 4, 5.
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Page 4 of 20Chlamydiae membrane proteins were collected from all
7 chlamydial proteomes using the Polyphobius predictor
algorithm [33]. Out of the 2904 sequences obtained, we
eliminated the sequences that only contained one hydro-
phobic N-terminus fragment identified as a signal pep-
tide or that contained a single transmembrane domain.
The remaining polytopic membrane proteins (1387
sequences) were submitted to the domain recognition
program rpsblast associated with the NCBI-CDD data-
base. Proteins generating multi-domain family hits
(COG, TIGRfam), highly indicative of a conserved pro-
karyotic function, were removed. In addition, sequences
containing a single domain covering the whole length of
the protein were analyzed with Blast. Among those, we
retained as candidates only the proteins specific to the
chlamydial genus. Finally at this stage, only sequences
containing at least one set of transmembrane domains
separated by a loop of less than 30 amino acids were
retained. Altogether, the seven chlamydial proteomes
generated 537 sequences that fulfilled these criteria. The
number of putative Inc proteins per chlamydial species
ranges from 76 out of 2031 proteins (4%) in P. amoebo-
phila to 107 out of 1052 proteins (10%) in C. pneumo-
niae (Figure 2A). The list of putative C. trachomatis and
C. pneumoniae Inc proteins are shown in Table 2 and 3,
respectively, while putative Inc proteins from other gen-
omes are found in Additional files 1, 2, 3, 4 and 5.
We next studied the evolutionary relationship of the
putative Inc proteins using InParanoid/Multiparanoid
programs, which can automatically find orthology rela-
tionships between proteins in multiple proteomes [34].
From the 537 Inc-candidates sequences, 126 are
“orphan” sequences, showing no orthology relationship
with other putative Inc. Most of these orphan putative
Inc proteins are from P. amoebophila (68 sequences)
and from C. pneumoniae (36 sequences). The remaining
411 putative Inc proteins come into 109 groups of
orthologs. Interestingly, 50 and 21 of the ortholog
groups were specific of the Chlamydophila and of the
Chlamydia families, respectively (Figure 2B). This sug-
gests that many Inc proteins might fulfill species-specific
or family-specific functions. Alternatively, and not exclu-
sively, Inc proteins that are involved in similar functions
in distinct species might not be recognizable at the pri-
mary sequence level.
Genes coding for Inc proteins are scattered in the
genomes with a few “hot spots” that cluster several con-
secutive inc genes (see in Figure 2C the distribution of
C. trachomatis inc genes as an example). Transcription
of the genes in operons has been demonstrated in a few
cases [14,15]. Finally, Inc proteins have an average
length of 279 residues (median: 207, ranging from 61 to
1537 residues). Most members of the family have only
two transmembrane segments. Inc proteins with four
transmembrane segments have been observed [16,26,35],
but the existence of Inc proteins with more than four
transmembrane segments remains to be confirmed
experimentally.
Experimental validation of the results
We had previously shown that three C. pneumoniae and
nine C. trachomatis Inc proteins had an amino-terminal
sequence that was recognized as a TTS signal in Shigella
flexneri, strongly suggesting that TTS is the mechanism
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Groups of orthologs shared by all 
Chlamydiacae (6 genomes)  162  25  15% 
Groups of orthologs shared only by 
Chlamydophila (4 genomes)  105 50  47% 
Groups of orthologs shared only by 
Chlamydia (2 genomes)  30 21  70% 
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Figure 2 Distribution of the putative Inc proteins among the
seven genomes. A. Numbers of putative Inc proteins in each
genome. B. Conservation of putative Inc proteins between genomes
based on groups of orthologs shared by all Chlamydiales,
Chlamydiaceae only (not found in P. amoebophila), Chlamydophila
only (not found in P. amoebophila or Chlamydia), Chlamydia only
(not found in P. amoebophila or Chlamydophila). C. Distribution of
putative inc genes on C. trachomatis genome. The genes are
represented in blue on two circles, representing the two coding
strands. Red lines indicate the position of the putative inc genes.
The figure was constructed using DNA Plotter [72].
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Page 5 of 20Table 2 C. trachomatis D/UW-3/CX putative Inc proteins
Sequence
ID
0rtholog
Group # (1)
Length
(aa)
TM
segments
(2)
TM coordinates (3) Additional feature(s)
CT005 667 363 4 [34-54]6[60-81]5[95-119]6[124-146]
CT006 485 189 3 [89-112]5[117-138]
CT018 714 157 3 [91-105]2[107-121]
CT036 989 403 2 [28-50]6[56-75]
CT058 722 367 2 [26-48]5[53-76] Macro domain
CT079 580 147 2&SP [SP 1-13][35-68]13[81-102]
CT081 983 98 2 [39-58]12[70-96]
CT101 236 153 3&SP [SP 1-25]-[38-56] & [95-113]6[119-138]
CT115 987 141 2 [37-61]7[68-93] Inclusion Membrane Protein D
(IncD)
CT116 982 132 2 [36-59]5[64-87] Inclusion Membrane Protein E
(IncE)
CT117 961 104 2 [38-62]8[70-91] Inclusion Membrane Protein F
(IncF)
CT118 988 167 2 [33-57]6[63-88] Inclusion Membrane Protein G
(IncG)
CT119 264 273 2 [35-59]5[64-84] Inclusion Membrane Protein A
(IncA) extended coiled coils
CT134 980 137 3 [80-98]7[105-122]
CT135 713 360 3 [210-236]6[242-268]
CT147 553 1449 4 [79-99]6[105-124] & [849-870]6[876-896] extended coiled coils
CT164 No ortholog 86 2 [31-53]7[60-80]
CT179 682 170 2 [2-19]11[30-52]
CT192 969 257 2 [58-81]6[87-108]
CT195 132 363 6 [53-74]7[81-104] & [173-194]2[196-215] & [238-252]2[254-268]
CT196 977 106 2 [34-57]6[63-85]
CT214 877 547 3 [36-58]6[64-89]
CT222 No ortholog 129 2 [39-63]6[69-93]
CT223 842 270 3 [38-61]6[67-91] & [180-194] extended coiled coils
CT224 No ortholog 147 2 [35-58]8[66-87]
CT225 No ortholog 122 2 [12-38]6[44-66]
CT226 979 176 2 [45-68]6[74-99] coiled coils and Leucine zipper
CT227 963 133 2 [36-64]2[66-88]
CT228 964 196 2 [38-59]6[65-86] coiled coils
CT229 965 215 2 [42-65]6[71-90] coiled coils
CT232 79 115 2 [31-61]6[67-90]
CT233 26 178 2 [100-127]13[140-164] Inclusion Membrane Protein B
(IncB)
CT249 966 116 2 [51-72]6[78-97] Inclusion Membrane Protein C
(IncC)
CT288 774 563 4 [36-58]7[65-88] & [242-263]6[269-291] coiled coils
CT300 990 115 2 [34-54]12[66-95]
CT324 772 303 3 [75-93]6[99-119]
CT326 462 563 4 [323-337]2[339-353]12[365-382] & [438-461] DUF687
CT345 972 121 2 [31-53]6[59-82]
CT357 986 110 2 [37-58]6[64-86]
CT358 968 178 2 [45-70]6[76-100]
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Page 6 of 20by which Inc proteins are exported to the inclusion sur-
face [24,36]. This property, which is independent of the
characteristics of Inc proteins on which the biocomput-
ing approach was based, was used to validate our
in silico results. We included in the experiment 16 of
the C. trachomatis and C. pneumoniae putative Inc pro-
teins for which we had localization data and which had
not been previously tested in the Shigella assay (Table 1
and 4). Because such data are scarce in the case of
C. pneumoniae, we also included putative Inc proteins.
Those were randomly chosen except for CPn0284 and
CPn0285, which were included because they had not
been observed on the inclusion membrane [37]. To
determine whether putative Inc proteins contained a
TTS signal we constructed chimeras between the
amino-terminal part of the putative Inc proteins and a
reporter protein, the calmodulin-dependent adenylate
cyclase (Cya). Constructs were introduced into S. flex-
neri strains expressing various phenotypes with respect
to type III secretion, i.e. in which secretion was constitu-
tively turned on (ipaB mutant) or deficient (mxiD
mutant). Secretion was assayed on colonies grown on
agar plates: secreted chimera diffuse in the agar during
overnight growth of the colony, while non-secreted chi-
mera remain associated to the bacteria. After transfer on
a nitrocellulose membrane and western blot against the
Cya reporter protein, the secreted chimera appear as a
halo around the colony, while the non secreted con-
structs are only visible at the spot where the colony
grew [36]. About half of the chimeras were seen to be
translocated by a TTS dependent process by this assay
(Figure 3A). All chimeras that did not show a secretion
pattern in the colony assay were tested again in liquid
culture conditions [24], which is slightly more sensitive,
to exclude the possibility that secretion occurred but
was below detection level with the secretion assay on
colonies. After subcellular fractionation of a culture of
the ipaB or mxiD strains transformed with a chimeric
construct, the presence of the chimera was assayed by
western blot in the pellet and supernatant fractions.
Seventeen out of the 23 chimera tested in this assay
were found in the supernatant when expressed in the
ipaB strain and not in the mxiD strain (Figure 3B). To
verify that the presence of the chimera in the superna-
tant was not due to bacterial lysis, the fractions were
also probed with an antibody against the cytosolic cyclic
AMP receptor protein (CRP). Finally, probing the mem-
branes with an antibody against the endogenous type III
secretion substrate IpaD showed that type III secretion
was functional in each of the transformed ipaB cultures.
Table 2 C. trachomatis D/UW-3/CX putative Inc proteins (Continued)
CT365 141 575 10 [54-77]6[83-105]20[125-146]15[161-179]29 [208-233]6[239-262]
& [338-360]6[366-392] & [471-491]6[497-517]
CT383 238 243 2 [104-130]6[136-157]
CT440 411 112 2 [32-53]7[60-85]
CT442 515 150 2 [38-61]6[67-88] 15 kDa Cysteine-Rich Protein
(CrpA)
CT449 976 110 2 [42-63]6[69-87]
CT483 316 121 2 [39-62]20[82-105]
CT484 467 332 2 [29-51]6[57-80] Tetratrico Peptide Repeats (TPRs)
CT556 496 159 2 [100-123]12[135-152]
CT565 340 147 2 [49-81]25[106-135]
CT616 286 429 2 [39-59]6[65-84] UPF0242 extended coiled coils
CT618 612 266 2 [213-236]6[242-262]
CT642 344 271 2 [167-188]2[190-205]
CT788 597 166 2 [6-26]7[33-54]
CT789 No ortholog 83 2 [12-30]28[58-78]
CT813 978 264 2 [41-61]7[68-94] coiled coils
CT814.1 160 120 3 [6-32]20[52-69]28[97-116]
CT837 176 658 2 [543-561]12[573-592]
CT850 151 405 4 [24-46]2[48-68] & [71-91]4[95-119] extended coiled coils
CT873 No ortholog 105 2 [29-43]2[45-59]
TOTAL 59 proteins
(1) Number of the group of orthologs to which the protein belongs (2) total number of transmembrane segments detected by Polyphobius predictor algorithm
(transmembrane segments identified as signal peptides are noted SP). (3) [first-last] amino acid of the transmembrane segment for each bilobal domain, the
number of amino acids in the loop appears in bold. Additional features contain information extracted from genome annotations and from the present analysis.
Dehoux et al. BMC Genomics 2011, 12:109
http://www.biomedcentral.com/1471-2164/12/109
Page 7 of 20Table 3 C. pneumoniae CWL029 putative Inc proteins, see Table 2 for details
Sequence
ID
0rtholog
Group # (1)
Length
(aa)
TM
segments
(2)
TM coordinates (3) Additional feature(s)
CPn0007 688 964 6 [7-30]10[40-61] & [116-140]10[150-171] & [226-250]6[256-281] DUF1978 coiled coils
CPn0010 688 297 2 [2-16]9[25-46] extended coiled coils
CPn0011 688 241 2 [30-53]6[59-85] extended coiled coils
CPn0026 no ortholog 288 2 [37-63]5[68-89]
CPn0028 950 261 3 [48-64]9[73-87]2[89-103] DUF648
CPn0034 908 416 2 [52-76]6[82-105] Macro domain
CPn0041 688 449 2 [2-16]9[25-46] DUF1978 coiled coils
CPn0043 688 642 2 [29-52]7[59-80] DUF1978 extended coiled
coils
CPn0045 688 574 2 [2-16]9[25-46] DUF1978 coiled coils
CPn0049 505 160 3 [49-69] & [102-118]2[120-141]
CPn0065 774 576 4 [33-55]6[61-88] & [242-263]6[269-291] coiled coils
CPn0066 462 577 5 [358-379]14[393-413]12[425-445] & [484-507] & [542-566] DUF687
CPn0067 no ortholog 367 2 [34-58]6[64-84]
CPn0069 462 617 5 [398-419]15[434-455]10[466-488] & [526-547] & [585-608] DUF687
CPn0072 772 335 3 [91-109]6[115-135] & [166-194]
CPn0124 688 485 2 [2-18]10[28-49] DUF1978 coiled coils
CPn0126 688 759 2 [2-17]10[27-48] DUF1978 extended coiled
coils
CPn0130 no ortholog 165 2 [29-51]5[56-77]
CPn0131 no ortholog 344 2 [36-55]6[61-81]
CPn0132 no ortholog 325 2 [29-53]6[59-84]
CPn0146 287 161 3 [6-25]12[37-59]6[64-91]
CPn0147 455 149 2 [43-64]6[70-93]
CPn0150 553 1537 4 [79-99]6[105-124] & [841-861]6[867-886] extended coiled coils
CPn0157 916 142 2 [60-74]2[76-90] DUF648
CPn0164 no ortholog 167 2 [37-58]6[64-86]
CPn0166 no ortholog 111 2 [35-58]6[64-86]
CPn0169 no ortholog 264 2 [32-53]6[59-80]
CPn0173 no ortholog 91 2 [37-55]7[62-79]
CPn0174 568 156 2 [50-74]11[85-107] coiled coils
CPn0181 no ortholog 133 2 [73-91]16[107-125]
CPn0186 264 390 2 [38-62]6[68-88] similarity to CT119 IncA
extended coiled coils
CPn0203 916 265 2 [25-43]20[63-82] DUF648
CPn0211 no ortholog 98 2 [37-61]7[68-91]
CPn0212 no ortholog 393 2 [38-61]6[67-88]
CPn0214 no ortholog 404 2 [2-20]9[29-52] coiled coils
CPn0215 no ortholog 419 2 [31-57]6[63-88] extended coiled coils
CPn0216 no ortholog 145 2 [25-51]6[57-81]
CPn0221 804 136 3 [52-72]12[84-105]5[110-130]
CPn0223 461 126 2 [54-72]26[98-123]
CPn0225 no ortholog 223 2 [32-55]9[64-89] coiled coils
CPn0226 804 134 2 [56-76]14[90-121]
CPn0230 682 226 2 [41-65]12[77-100]
CPn0240 713 388 4 [79-93]12[105-133] & [188-215]7[222-248]
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CPn0241 713 384 4 [88-104]11[115-144] & [201-228]6[234-261]
CPn0242 63 144 3 [30-54] & [92-113]10[123-141]
CPn0243 63 141 3 [29-53] & [94-115]8[123-13]
CPn0266 129 231 4 [33-57]11[68-90] & [124-146]6[152-173]
CPn0267 129 263 4 [37-62]6[69-94] & [156-178]6[184-205]
CPn0277 no ortholog 169 2 [78-100]9[109-139]
CPn0284 no ortholog 165 2 [33-56]2[58-82]
CPn0285 475 515 2 [32-54]11[65-86]
CPn0288 132 382 6 [61-82]8[90-113] & [182-203]2[205-225]23[248-262]2[264-278]
CPn0291 79 176 2 [100-129]7[136-166] Inclusion Membrane Protein
B (IncB)
CPn0292 26 203 2 [127-151]19[170-193] Inclusion Membrane Protein
C (IncC)
CPn0308 no ortholog 121 2 [29-53]6[59-81]
CPn0312 236 151 3&SP [SP 1-24] [37-55] & [94-112]6[118-137]
CPn0334 580 171 3&SP [SP 1-26] [50-77]17[94-118]19[137-158]
CPn0334 580 171 3&SP [SP 1-26] [50-77]17[94-118]19[137-158]
CPn0352 654 419 2 [32-51]6[57-80] DUF1389
CPn0354 no ortholog 447 2 [26-50]2[52-74] DUF1389
CPn0355 no ortholog 433 2 [28-48]6[54-77] DUF1389
CPn0357 no ortholog 283 2 [27-52]5[57-76] DUF1389
CPn0365 no ortholog 339 2 [33-54]6[60-79]
CPn0366 no ortholog 155 2 [49-71]14[85-112]
CPn0367 722 245 2 [40-61]6[67-86] Macro domain
CPn0369 722 404 2 [39-60]6[66-86] Macro domain
CPn0370 722 371 2 [36-56]5[61-80] Macro domain
CPn0371 no ortholog 119 2 [43-65]6[71-92]
CPn0372 no ortholog 105 2 [36-62]6[68-90]
CPn0375 no ortholog 165 4 [49-73]6[79-103]9[112-131]6[137-155]
CPn0381 462 591 5 [372-393]15[408-428]11[439-459] & [498-521] & [557-581] DUF687
CPn0404 402 339 3 [123-137]2[139-153]4[157-174]
CPn0431 901 111 2 [39-60]11[71-92]
CPn0432 no ortholog 101 2 [36-59]6[65-86]
CPn0440 431 212 2 [54-72]6[78-101] coiled coils
CPn0442 485 172 3 [44-75]12[87-111]6[117-137]
CPn0443 667 417 4 [53-74]6[80-102]12[114-138]6[144-165]
CPn0458 no ortholog 695 2 [6-22]23[45-66] DUF562 and DUF575
CPn0474 141 589 10 [58-81]6[87-109]20[129-150]15[165-183]29[212-237]6[243-266] &
[345-367]6[373-400]12[472-492]6[498-518]
CPn0480 238 218 2 [101-127]10[137-159]
CPn0481 no ortholog 536 2 [31-52]6[58-84]
CPn0517 no ortholog 279 2 [39-63]7[70-93]
CPn0523 898 110 2 [26-47]2[49-73]
CPn0524 800 359 2 [35-57]6[63-82] Macro domain
CPn0537 160 119 3 [6-32]21[53-69]27[96-115]
CPn0554 411 96 2 [33-55]9[64-87]
CPn0556 515 196 2 [74-98]6[104-125] 15 kDa Cysteine-Rich
Protein (CrpA)
CPn0565 106 366 2 [39-58]6[64-85]
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Page 9 of 20Therefore, absence of the chimera in the supernatant of
t h e s ec u l t u r e sd i dn o tr e s u l tf r o mag e n e r a ld e f e c ti n
secretion but from the absence of a functional type III
secretion signal in the chimera.
Table 4 combines these results and previous work
[24,36]. Out of the 22 C. trachomatis putative Inc pro-
teins that we tested, 19 (86%) possessed a functional
TTS signal in their amino-terminal extremity. In
C. pneumoniae, 44 putative Inc proteins were tested and
the amino-terminal sequence of 41 (93%) were recog-
nized as TTS signals in S. flexneri. Since the C. pneumo-
niae candidates were chosen randomly, this number can
be extrapolated to the whole set of C. pneumoniae puta-
tive Inc proteins. It is very close to the proportion of
TTS found in C. trachomatis putative Inc proteins, sug-
gesting that the extrapolation is valid for all Chlamydia-
ceae, and that, overall, 90% of the putative Inc proteins
that we identified based on their hydrophobic profile
also possess a TTS signal.
Identification of an ADP-ribose binding domain in several
putative Inc proteins
Since Inc proteins are exposed to the host cytoplasm,
we reasoned that they might present eukaryotic-like fea-
tures. We used sensitive sequence analysis tools to
search for conserved domains in putative Inc proteins,
and in particular domains more abundant in eukaryotes.
Proteins containing such a domain would not have been
filtered out during the bioinformatics procedure if the
domain covered only a restricted portion of the whole
protein. Mimicry between Inc proteins and eukaryotic
domains were reported in the case of CT147, whose
overall structure resembles the early endosomal antigen-
1 [26], CPn0585, which shows some similarity with Rab
GTPase-interacting proteins [20], and IncA, which
mimics SNARE domains [13]. These features were only
noticed after careful sequence examination and cannot
be revealed with standard sequence comparison tools. It
is likely that primary sequence comparisons will fail to
reveal the function of most Inc proteins, thus other
methods need to be developed.
From their conservation within the Chlamydiale phy-
lum 7 domains of unknown functions were identified in
Inc proteins: DUF562 (in association with DUF575),
DUF648, DUF687, DUF1978, DUF1389 and UPF0242.
However, since these domains are only found in Chla-
mydiales, their identification does not give any clue on
their putative function.
Interestingly, the only conserved domains we found
were macro domains, which we discovered in 20
Table 3 C. pneumoniae CWL029 putative Inc proteins, see Table 2 for details (Continued)
CPn0585 842 651 2 [52-75]6[81-103] extended coiled coils
CPn0601 316 106 2 [36-61]12[73-101]
CPn0602 467 334 2 [29-51]6[57-80] Tetratrico Peptide Repeats
(TPRs)
CPn0753 612 282 2 [228-250]6[256-276]
CPn0755 286 401 2 [14-34]6[40-58] UPF0242 extended coiled
coils
CPn0770 344 264 2 [161-181]2[183-199]
CPn0822 340 158 3 [46-60]2[62-83]20[103-134]
CPn0829 no ortholog 185 2 [108-131]18[149-180]
CPn0830 no ortholog 172 3 [6-22] & [91-115]16[131-163]
CPn0834 496 154 2 [98-121]12[133-150]
CPn0882 462 379 5 [169-188]7[195-217]13[230-247]20[267-285] & [334-358] DUF687
CPn0930 no ortholog 158 2 [28-51]5[56-77]
CPn0938 597 158 2 [2-22]6[28-50]
CPn0994 176 681 2 [553-571]12[583-602] coiled coils
CPn1008 151 432 4 [34-55]2[57-77]3[80-99]6[105-130] extended coiled coils
CPn1027 no ortholog 527 2 [34-58]6[64-89] coiled coils
CPn1029 226 279 6 [28-46]14[60-84]21[105-132]17[149-175]21[196-217]20[237-263]
CPn1051 no ortholog 103 2 [36-62]5[67-91]
CPn1054 688 811 2 [28-52]11[63-83] DUF1978 extended coiled
coils
CPn1055 688 276 2 [2-16]5[21-46] DUF1978 extended coiled
coils
TOTAL 107 proteins
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Page 10 of 20Table 4 Localization and presence of a Type III secretion
signal in C. trachomatis and C. pneumoniae putative Inc
proteins
Sequence ID
(C. trachomatis)
Localization TTSS
CT005
CT006
CT018
CT036
CT058 Bacteria Y (Figure 3A)
CT079
CT081
CT101 Inclusion
CT115_IncD Inclusion Y [36]
CT116_IncE Inclusion Y [36]
CT117_IncF Inclusion
CT118_IncG Inclusion Y [36]
CT119_IncA Inclusion Y [36]
CT134
CT135
CT147 Inclusion
CT164
CT179
CT192 Bacteria N (Figure 3B)
CT195 Bacteria Y (Figure 3A)
CT196
CT214
CT222 Inclusion
CT223 Inclusion Y [36]
CT224
CT225 Inclusion
CT226 Inclusion Y (Figure 3A)
CT227
CT228 Inclusion Y (Figure 3A)
CT229 Inclusion Y [36]
CT232_IncB Inclusion
CT233_IncC Inclusion Y [36]
CT249 Inclusion Y (Figure 3A)
CT288 Inclusion Y [36]
CT300
CT324 Y (Figure 3A)
CT326
CT345
CT357
CT358 Inclusion Y (Figure 3A)
CT365
CT383 Bacteria Y (Figure 3A)
CT440 Inclusion Y (Figure 3A)
CT442 Inclusion Y [36]
Table 4 Localization and presence of a Type III secretion
signal in C. trachomatis and C. pneumoniae putative Inc
proteins (Continued)
CT449
CT483
CT484 Bacteria N (Figure 3B)
CT556
CT565 Bacteria N (Figure 3B)
CT578
CT616
CT618 Inclusion
CT642
CT645
CT788
CT789
CT813 Inclusion
CT814.1
CT837
CT850 Inclusion Y (Figure 3B)
CT873
Sequence ID
(C. pneumoniae)
Localization TTSS
CPn0007
CPn0010
CPn0011
CPn0026 Y [24]
CPn0028 Y (Figure 3B)
CPn0034
CPn0041
CPn0043
CPn0045
CPn0049 Y (Figure 3B)
CPn0065
CPn0066
CPn0067 Y (Figure 3A)
CPn0069
CPn0072 Y (Figure 3B)
CPn0124
CPn0126
CPn0130 Y (Figure 3A)
CPn0131
CPn0132 Y (Figure 3A)
CPn0146 Inclusion Y (Figure 3A)
CPn0147 Inclusion
CPn0150
CPn0157
CPn0164
CPn0166
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Page 11 of 20Table 4 Localization and presence of a Type III secretion
signal in C. trachomatis and C. pneumoniae putative Inc
proteins (Continued)
CPn0169 Bacteria N (Figure 3B)
CPn0173
CPn0174 Y (Figure 3A)
CPn0181 Y (Figure 3A)
CPn0186 Inclusion Y [24]
CPn0203
CPn0211 Bacteria Y (Figure 3B)
CPn0212
CPn0214
CPn0215 Y (Figure 3B)
CPn0216
CPn0221
CPn0223 Y (Figure 3A)
CPn0225
CPn0226
CPn0230 Bacteria Y (Figure 3B)
CPn0240
CPn0241 Y (Figure 3B)
CPn0242
CPn0243 Y (Figure 3A)
CPn0266
CPn0267 Y (Figure 3A)
CPn0277 Y (Figure 3A)
CPn0284 Bacteria Y (Figure 3A)
CPn0285 Bacteria Y (Figure 3B)
CPn0288 Y (Figure 3B)
CPn0291 Y [24]
CPn0292 Y [24]
CPn0308 Inclusion Y [24]
CPn0312
CPn0334
CPn0352
CPn0354 Y (Figure 3B)
CPn0355 Bacteria Y (Figure 3B)
CPn0357 Bacteria Y (Figure 3A)
CPn0365 Y (Figure 3A)
CPn0366
CPn0367
CPn0369
CPn0370
CPn0371
CPn0372 Y (Figure 3B)
CPn0375
Table 4 Localization and presence of a Type III secretion
signal in C. trachomatis and C. pneumoniae putative Inc
proteins (Continued)
CPn0381
CPn0431
CPn0432
CPn0434
CPn0440
CPn0442 Y (Figure 3B)
CPn0443 Y (Figure 3A)
CPn0458
CPn0474 Y (Figure 3A)
CPn0480 Y (Figure 3A)
CPn0481
CPn0517 Inclusion
CPn0523
CPn0524
CPn0537
CPn0554
CPn0556
CPn0565 Y (Figure 3B)
CPn0585 Inclusion Y [24]
CPn0601 Y (Figure 3B)
CPn0602 Bacteria Y (Figure 3B)
CPn0753
CPn0755
CPn0767
CPn0770 Y (Figure 3A)
CPn0822 N (Figure 3B)
CPn0829 Y (Figure 3A)
CPn0830
CPn0834
CPn0882
CPn0930
CPn0938
CPn0994
CPn1003
CPn1008 Bacteria N (Figure 3B)
CPn1027 Inclusion Y (Figure 3A)
CPn1029
CPn1051
CPn1054
CPn1055
Novel localization data from this study are in bold. TTS data are from this
study (Figure 3) or from previous study [36] and [24]. References for the
localization data are found in Table 1 or in [18].
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Page 12 of 20putative Inc proteins. The macro (or A1pp) domain is a
module of about 180 amino acids which binds ADP-
ribose and ADP-ribosylated proteins [38,39] and possi-
bly a variety of related metabolites [40]. Macro domain
proteins are found in eukaryotes, in bacteria, in archaea
and in ssRNA viruses. While absent from the list of
P. amoebophila putative Inc proteins, at least one macro
domain was found in the six lists of Chlamydiaceae
putative Inc proteins, and the motif appears to have
expanded in the Chlamydophila lineage (Table 2, 3 and
Additional files 1, 2, 3, 4, 5). The presence of a macro
domain at the inclusion membrane could allow the
Figure 3 Identification of type III secretion signals in putative Inc proteins. A. Secretion assay on colonies. The ipaB (left) or mxiD (right)
strains of S. flexneri were transformed with different Chlamydia/Cya constructs, isolated, and one colony for each construct was grown overnight
in contact with a PVDF membrane, which served the following day to reveal the localization of the reporter protein using anti-Cya antibodies.
All chimera shown in this figure carry a functional TTS assay, which allow the chimera to diffuse in a halo in the ipaB strain but not in the mxiD
strain. B. Secretion assay in liquide cultures. Exponential cultures of ipaB or mxiD strains expressing the indicated chimeras were fractionated. The
supernatant (S) and pellet (P) fractions were run on SDS-PAGE and western blot was performed using anti-Cya antibody. Membranes were later
probed again using anti IpaD and anti CRP antibodies, to check that there was no bacterial lysis and that TTS was functional in the ipaB strain.
These controls were systematically performed and are only shown for the first row of constructs tested. The supernatant fractions is
concentrated 25-fold compared to the pellet fraction. Note that CPn0169/Cya is detectable in the culture supernatant, but in very low
proportion relative to its very high expression level. This is unlike other secreted chimera, we therefore concluded that this protein does not
carry a functional TTS signal.
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Page 13 of 20bacteria to recruit NAD
+-derived metabolites or ADP-
ribosylated proteins to the inclusion membrane to fulfill
various functions, depending on the specificity of these
bacterial macro domains. However, the presence of a
bacterial encoded macro domain at the inclusion mem-
brane during infection remains to be confirmed by
immunolocalization data, because the only member that
has been investigated so far, CT058, was not detected at
the inclusion [18].
Secondary structure analysis of putative Inc proteins
We next analyzed the predicted secondary structure of
putative Inc proteins. Excluding the bilobal hydrophobic
domain from the calculation, 153 sequences out of 537
exhibited an alpha-helix content superior to 50%. Alpha
helix-rich regions often constitute supersecondary struc-
t u r e ss u c ha sc o i l e d - c o i l sa n dh e l i c a lb u n d l e sa n da r e
encountered in many virulence effectors [41,42]. A very
common structure mediating protein-protein interac-
tions is the 34 amino acid helix-turn-helix motif formed
by tetratricopeptide motif repeats (TPR) [43]. Using two
prediction programs (Coils and Marcoils), we detected a
number of alpha helix-rich Inc proteins with a high pro-
pensity to have coiled coil regions. Among those, 64
proteins in 9 ortholog groups are predicted to form
extended (> 75 residues) coiled coil domains (Table 2, 3
a n dA d d i t i o n a lf i l e s1 ,2 ,3 ,4 ,5 ) .T h en u m b e ro fr e s i -
dues predicted to form coiled coils with a threshold of
50% (Marcoils) was found to be significantly enriched in
the putative C. trachomatis Inc protein population com-
pared to non Inc proteins with at least one transmem-
brane segment (Student’s t-test t = 3,1, p < 0.0001)
The two programs sometimes generated different pre-
dictions, suggesting that the alpha helical structures may
present discontinuities in the heptad pattern or organize
into amphiphilic helix or solenoid superhelical struc-
tures. Indeed, most alpha-helices of more than 25 resi-
dues not predicted to form coiled coils adopt an
amphiphilic conformation. In addition, seven sequences,
all belonging to the same chlamydial specific ortholog
group, are predicted to form solenoid superhelical struc-
tures characteristics of TPR repeats.
Many C. pneumoniae putative Inc proteins are not
translocated to the inclusion in the laboratory conditions
Inc proteins were initially defined as chlamydial proteins
that localized to the inclusion membrane during infec-
tion [10,14]. Later, the presence of at least one bilobed
hydrophobic domain was identified as a feature common
to all Inc proteins [16], and it is widely accepted that
these two characteristics define the members of the
family. Did our systematic search for proteins with a
bilobed hydrophobic domain identify proteins that all
localize to the inclusion membrane? The early work by
Bannantine et al suggested a negative answer to this
question since, out of the six putative Inc proteins
investigated using specific antibodies, one (CT484) was
associated with the bacteria but not the inclusion mem-
brane [16]. We recently extended this observation show-
ing that 5 additional C. trachomatis putative Inc were
only found inside the inclusion [18] (see Table 4). These
results show that the presence of a bilobed hydrophobic
domain does not guarantee translocation to the inclu-
sion membrane, at least for C. trachomatis Inc proteins.
To know whether this result also applied to C. pneumo-
niae, we raised antibodies against 7 putative Inc proteins
from C. pneumoniae (CPn0169, CPn0211, CPn0230,
CPn0355, CPn0357, CPn0602 and CPn1008) as GST-
tagged fusion proteins. As a control we used antibodies
against the C. pneumoniae Inc protein CPn0186. The
anti-fusion protein antibodies were used to localize the
endogenous proteins in cells infected by C. pneumoniae
for 96 hours. In contrast to the inclusion labeling
observed with anti-CPn0186 antibodies, none of the 7
sera stained the inclusion membrane (Figure 4). The
detection of endogenous antigens was removed by pre-
absorption with corresponding GST fusion proteins but
not heterologous GST fusion proteins, demonstrating
t h es p e c i f i c i t yo ft h ea n t i b o d i e s .W h i l et h e yd i dn o t
stain the inclusion membrane, the 7 sera labeled the
bacteria, demonstrating that the corresponding proteins
are expressed at this stage of infection, and remain bac-
teria-associated. We cannot exclude the possibility that
some or all of these proteins are partially exposed on
the membrane and not detected by this approach. How-
ever, we can conclude that these 7 putative Inc proteins
are not constitutively secreted. Table 4 recapitulates the
list of putative Inc proteins for these two species with
the TTS and localization data.
Discussion and Conclusions
Initially, to identify all putative Inc proteins, we started
from the IncA domain from Pfam database (PF04156),
which is derived from the multiple alignment of IncA-
like sequences. This domain includes the hydrophobic
domain and an adjacent coiled coil region, which are
characteristics of IncA. When used to detect Inc pro-
teins, this model misclassified Inc proteins sequences
which are devoid of coiled coil regions and appeared far
down in noise rank, with a non-significant Score/Evalue
(e.g. IncB-C-D-E-F-G). This indicates that the Pfam
IncA domain is too specific for a large scale genomic
analysis. Known Inc proteins contain two transmem-
brane alpha-helical segments separated by a loop of less
than 30 amino acids. Using this criteria and bioinfor-
matics tools, we have searched for all putative Inc pro-
teins in seven chlamydial proteomes and obtained 537
candidates. These results were validated experimentally
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Page 14 of 20Figure 4 Localization of 7 putative inclusion membrane proteins in C. pneumoniae-infected cells. HeLa cells infected with C. pneumoniae
AR39 for 96 hrs were immunostained with mouse anti-GST fusion protein antibodies plus a Cy3-conjugated goat anti-mouse IgG (red) and a
rabbit anti-chlamydial organism antibody plus a Cy2-conjugated goat anti-rabbit IgG (green) and Hoechst to visualize DNA (blue). Antibodies
against the GST-putative Inc fusion proteins detected signals inside the inclusions, overlapping with the chlamydial organisms. In contrast,
antibodies against GST-CPn0186, a control Inc protein, showed peripheral labelling of the inclusion membrane (bottom panels). All antibody
labelings were removed by preabsorption of the antibodies with the corresponding GST fusion proteins (panels i to p), but not the unrelated
GST-fusion protein control (q to x).
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Page 15 of 20for C. trachomatis and C. pneumoniae, as we found that
90% of the putative Inc proteins of these species had a
TTS signal, which is a property of Inc proteins indepen-
dent of their hydrophobicity profile.
Secondary structure analysis revealed that Inc proteins
are enriched in coiled-coil domains. In bacteria, coiled-
coil containing proteins represent 5% of proteins, and the
majority contain only one helix of around 28 residues
[44]. Extended coiled-coil domains are rare [45] and are
enriched in type III (and type IV) secretion proteins [42].
Motor, membrane tethering, and vesicle transport pro-
teins are the dominant eukaryote-specific long coiled-coil
proteins, suggesting that coiled-coil proteins have gained
functions in the increasingly complex processes of sub-
cellular infrastructure maintenance and trafficking con-
trol of the eukaryotic cell [46]. Therefore, the abundance
of sequences with a high probability for coiled-coil con-
formation among the putative Inc proteins supports the
hypothesis that these proteins are exposed on the cytoso-
lic side of the inclusion membrane where they may parti-
cipate in controlling the interaction between the
inclusion and the cellular compartments of the host and/
or to the motion of the inclusion in the cell, as we have
previously shown in the case of IncA [13].
We have identified a TTS signal in 90% of the 66
putative Inc proteins of C. trachomatis and C. pneumo-
niae that we have tested. This result confirms the
robustness of our secretion assay, for which we had pre-
viously demonstrated that the rate of false positive was
below 5% [36]. Approximately 10% of the 66 putative
Inc proteins tested did not have a functional TTS signal.
N o n eo ft h ef i v ep u t a t i v eI n cp r o t e i n sf o rw h i c ht h e
secretion assay gave a negative result and for which we
have localization data was detected on the inclusion
membrane, suggesting that they might correspond to
real negatives.
Three different methods have recently been made
available to predict TTS signals in the amino-terminal
part of proteins ([47,48] and http://gecco.org.chemie.
uni-frankfurt.de/T3SS_prediction/T3SS_prediction.html.
We found that 64% (38/59) C. trachomatis putative Inc
proteins were predicted to possess a TTS signal by at
least one of the three softwares, and 45% (27/59) by at
least two. Thus, although clearly successful at recogniz-
ing TTS signals, the current predicting tools have a
higher rate of false negative than our experimental
secretion assay. Conversely, 3 of the 6 proteins in which
we did not find a functional TTS were predicted to have
one by one program, again pointing to the successes and
limits of in silico detection tools for TTS signals.
The amino-terminal sequence of only about 10% of
the putative Inc proteins, for each species, was not
recognized for TTS in S. flexneri (CT192, CT484,
CT565, CPn0169, CPn0822 and CPn1008). Several
explanations for these negative results can be proposed:
(i) these putative Inc proteins might have lost their abil-
ity to be secreted, (ii) the sequence we considered as
coding for the N-terminal segment might not corre-
spond to the real N-terminal segment (for example
from sequencing or annotation errors), (iii) in the chi-
mera, the N-terminal segment might not be presented
in a conformation compatible with its recognition by
the S. flexneri TTS machinery, leading to a false negative
result in our assay. Interestingly, both orthologous pro-
teins CT565 and CPn0822 were not recognized as TTS
substrates, suggesting the TTS signal may have been
lost before speciation of the two lineages. In contrast,
CPn0602 has a functional TTS signal while the ortholo-
gous protein CT484 has none, suggesting that the ability
to be secreted was lost in the C. trachomatis lineage
only. The reverse might apply to CT850, which is
secreted, while the homologous protein CPn1008 is not.
Finally, the amino terminal part of CT192 is missing
from other C. trachomatis serovars, as well as from the
C. muridarium homolog, while the rest of the protein is
very conserved. This might reflect the absence of evolu-
tionary pressure to keep the amino-terminal domain
compatible with TTS in this protein, suggesting that
CT192 is not a TTS substrate.
Finally, in agreement with earlier observations [16,18],
we observed that not all putative Inc proteins are
detected on the inclusion membrane using specific anti-
bodies. Localization data are now available for 16
C. pneumoniae putative Inc proteins. Only 7 of them
(44%) were detected on the inclusion membrane (Table
4). If this number can be extrapolated to the whole gen-
ome, only about 47 out of the 107 putative C. pneumo-
niae Inc proteins might be exposed at the inclusion
surface in the culture model we use (HeLa cells), mean-
ing that the expansion of putative Inc proteins coded by
C. pneumoniae genome does not necessarily correlate
with an increase in the number of bacterial proteins
exposed at the inclusion surface in this species. In com-
p a r i s o no n l y6o u to f2 9( 2 0 % )C. trachomatis Inc pro-
teins for which localization data were obtained were not
detected at the inclusion membrane. This suggests that
in this species the pool of ‘non-translocated Inc proteins’
might be smaller than in C. pneumoniae. However, the
C. trachomatis proteins analyzed were not randomly
chosen thus making the comparison difficult.
We showed that 3 out of the 6 putative C. trachomatis
Inc proteins that were only detected on the bacteria had
a functional TTS signal (in C. pneumoniae,7o u to f9
such proteins had a functional TTS signal). Therefore,
although some of these ‘non-translocated Inc proteins’
might correspond to false positives of the biocomputing
approach, other explanations are needed to account for
the absence of detection at the inclusion membrane of
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Page 16 of 20many putative Inc proteins. Firstly, it could be that only
a small proportion of these putative Inc proteins is
translocated and could be undetected by our method.
Alternatively, they might bes e c r e t e dv e r ye a r l yi nt h e
developmental cycle. At early time points, it is difficult
to distinguish between the inclusion and bacterial mem-
branes and a transient appearance at the inclusion sur-
face would be difficult to detect. Both scenarios raise
the question of the difference between ‘poorly’ or ‘tran-
siently’ translocated Inc proteins and other Inc proteins.
Alternatively, ‘non-translocated Inc proteins’ might cor-
respond to former inclusion proteins that have lost their
function as such and are no longer secreted. Consider-
ing the drastic genome reduction observed in all chla-
mydiae, the maintenance of these genes imply that all of
these proteins must have acquired another intrabacterial
function, which makes this explanation very unlikely.
Another hypothesis is that translocation of some Inc
proteins is controlled and responds to unknown stimuli,
which are absent from the culture conditions used here.
In other bacteria, many TTS substrates are stored,
usually in complex with chaperone proteins, before
translocation by the TTS apparatus upon stimulation
[49]. In addition to their distribution in inclusion mem-
branes, several Inc proteins were detected in purified
bacteria, indicating that the Inc proteins might be stored
to some extent before translocation [10,15]. We have
shown that Inc proteins were not soluble when
expressed in E. coli, suggesting that in chlamydiae
unknown chaperone protein(s) might assist their folding
and availability for translocation [24]. The observation
that some putative Inc proteins are mostly found at the
inclusion membrane while others are only detected in
the bacteria suggest that different pools of Inc proteins
exist, whose translocation into the inclusion membrane
responds to different cellular environment, cell types or
even hosts. Noticeably, the expansion of putative Inc
proteins in the C. pneumoniae genome compared to
C. trachomatis accounts for about one third of the dif-
ference in gene number between the two species. This
may reflect the need for C. pneumoniae to adapt to
more variable environments, consistent with the hypoth-
esis that certain Inc proteins may only be exposed on
the surface of the inclusion in a regulated manner.
Methods
Sequence analysis
Proteomes data set
The protein sequences were retrieved from completely
sequenced genomes of the following chlamydial species:
C. abortus S26 3, C. muridarum strain Nigg, C. pneumo-
niae CWL029, C. trachomatis serovar D/UW-3/CX,
C. caviae GPIC, C. felis Fe/C-56, Candidatus ‘Protochla-
mydia amoebophila’ UWE25. Chlamydial proteomes
were retrieved from the Comprehensive Microbial
Resource (CMR) site.
Analysis of hydrophobic domains was conducted for
membrane protein secondary structure prediction by the
SPLIT program [28] and for topology analysis with Top-
cons program, which combines results of several predic-
tors to yield a more reliable result [31].
Clustering of Orthologs: groups of ortholog in the
seven genomes/proteomes were obtained using the All-
versus-All sequences comparison InParanoid method
and its extention MultiParanoid, which merge multiple
pairwise ortholog groups from InParanoid into multi-
species ortholog groups [34,50]. Each group of orthologs
was given a number, which is reported in Tables 2, 3
and Additional files 1, 2, 3, 4, 5.
Transmembrane protein were collected with the
Polyphobius program which combines transmembrane
detection and signal peptide prediction. The method
makes an optimal choice between transmembrane seg-
ments and signal peptides, and also allows constrained
and homology-enriched predictions [33]. To reduce mis-
classification, proteins with a single transmembrane
domain and a signal peptide were analyzed manually.
Protein domain detection were performed with
rpsblast program (Blast package v2.2.19) [51] using the
NCBI Conserved Domain Database (CDD, v2.18) [52]).
Specific searches of domains were performed with the
Hmmer package [53,54].
Multiple alignment and domain detection
Multiple sequence alignments were performed with the
PralineTM program, which optimizes the information
for each of the input sequences (predicted secondary
structure and transmembrane structure) [55].
Charge distributional analysis was performed with
SAPS [56].
Secondary structure analysis
Secondary structure prediction was performed with the
Proteus program (v2) [57]. To optimize the selection of
proteins with coiled-coil regions we used two different
approaches: firstly the Coils program [58] with windows of
28, 21 and 17 residues, and secondly the Maircoil program
[59]. We considered high coiled coil predictions when
both algorithms returned high probabilities of coiled coils.
Other alpha helical conformations were predicted respec-
tively with Heliquest for amphiphilic conformations [60]
and TPRpred [61] for superhelical topologies as Tetratrico
Peptide Repeats, Pentratrico repeats and SEL1-like repeats.
Presence of Leucine zippers in coiled coils proteins were
performed using 2ZIP [62].
Type III secretion assays
Genomic DNA from C. pneumoniae strain TW183, C. tra-
chomatis serovar D/UW-3/CX and C. caviae strain GPIC
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Page 17 of 20was prepared from bacteria extracted from infected HeLa
cells, using the RapidPrep Micro Genomic DNA isolation
kit (Amersham Pharmacia Biotech). Chimera comprising
the 5’ part of different chlamydial genes upstream of the
gene coding for the adenylate cyclase of Bordetella pertus-
sis were constructed by PCR as described [24]. The con-
structs include about 30 nucleotides upstream from the
proposed translation start sites and the first 20 to 40
codons of the chlamydial genes. The chimeric constructs
were transformed in the S. flexneri strains SF401 and
SF620, which are derivatives of M90T in which the mxiD
and ipaB genes, respectively, have been inactivated [63,64].
Secretion on liquid cultures [24] and on colonies [36] were
assayed as described previously. Antibodies against the
cyclic AMP receptor protein (CRP) and against IpaD were
kindly given by A. Ullmann and C. Parsot, respectively
(Institut Pasteur).
Chlamydial gene cloning, fusion protein expression and
antibody production
The ORFs encoding putative inclusion membrane
proteins from the C. pneumoniae AR39 genome
http://stdgen.lanl.gov/ were cloned into the pGEX vec-
tors (Amersham Pharmacia B i o t e c h )a n de x p r e s s e da s
fusion proteins with a glutathione-S-transferase (GST)
fused at the N-terminus of the chlamydial proteins as
previously described [65,66]. The expression of these pro-
teins was induced by the addition of IPTG (Invitrogen)
and the fusion proteins were extracted by lysing the
bacteria via sonication in Triton X-100 lysis buffer
(1% Triton X-100, 1 mM PMSF, 75 units ml
-1 aprotinin,
20 mM leupeptin and 1.6 mM pepstatin). The GST fusion
proteins were purified using glutathione-conjugated
agarose beads (Pharmacia). The purified fusion pro-
teins were used to immunize mice for producing poly-
clonal antisera [67]. The sera were collected and stored
at -20°C until use.
Immunofluorescence assay
Monolayers of HeLa 229 cells grown on glass coverslips
were infected with Chlamydia pneumoniae AR39 at a
m.o.i. of 0.5 in the presence of 2 μg/ml cycloheximide.
The chlamydial organisms and infection procedures
were as described elsewhere [65,68]. Ninety-six hours
after infection cells were fixed with 2% paraformalde-
hyde (Sigma) dissolved in PBS for 30 min at room tem-
perature, followed by permeabilization with 0.1% Triton
in PBS for an additional 10 min. After washing and
blocking, the cell samples were subjected to antibody
and chemical staining. Hoechst (blue; Sigma) was used
to visualize DNA. A rabbit anti-chlamydial organism
antibody (R12AR39, raised with C. pneumoniae AR39
organisms; unpublished data) plus a goat anti-rabbit IgG
secondary antibody conjugated with Cy2 (green; Jackson
Immuno-Research Laboratories) was used to visualize
chlamydial inclusions. The polyclonal mouse antibodies
raised against putative inclusion membrane C. pneumo-
niae GST fusion proteins plus a goat anti-mouse IgG
conjugated with Cy3 (red; Jackson ImmunoResearch)
were used to visualize the corresponding antigens. In
some cases, the primary antibodies were pre-absorbed
with either the corresponding or heterologous fusion
proteins immobilized onto agarose beads (Pharmacia)
prior to staining cell samples. The preabsorption
approach was carried out by incubating the antibodies
with bead-immobilized antigens overnight at 4°C fol-
lowed by pelleting the beads. The remaining supernatants
were used for immunostaining. The immunofluorescence
images were acquired with an Olympus AX-70 fluores-
cence microscope equipped with multiple filter sets
(Olympus) as described previo u s l y[ 6 9 - 7 1 ] .B r i e f l y ,t h e
multi-colour-labelled samples were exposed under a
given filter set at a time and single color images were
acquired using a Hamamatsu digital camera. The single
color images were then superimposed with the software
SimplePCI. All images were processed using Adobe
Photoshop (Adobe Systems).
Additional material
Additional file 1: Table S1: Putative Inc proteins from C. muridarium.
Additional file 2: Table S2: Putative Inc proteins from C. felis.
Additional file 3: Table S3: Putative Inc proteins from C. caviae.
Additional file 4: Table S4: Putative Inc proteins from C. abortus.
Additional file 5: Table S5: Putative Inc proteins from Candidatus
‘Protochlamydia amoebophila’ UWE25.
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